BOSTON and LAUSANNE, Switzerland, Feb 16, 2022 — SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full year 2021 before U.S. markets open on Tuesday, March 15, 2022. SOPHiA will host a conference call and live webcast to discuss its financial results as well as business outlook beginning at 8:30 a.m. Eastern Time / 2:30 p.m. Central European Time.
The call will be webcast live on the SOPHiA Investor Relations website. Additionally, an audio replay of the conference call and webcast will be available on the website after its completion.